Use of Somatropin in Turner Syndrome

The Use of Norditropin® in Turner's Syndrome

This trial is conducted in Europe. The aim of this trial is to study the dose-response relationship and effect of somatropin (Norditropin®) on final height in girls with Turner Syndrome.

Inclusion Criteria:

• Turner Syndrome
• Not previously treated with growth hormone or androgen
• Well-documented height over the previous 12 months
• Informed consent of parents (and child if appropriate)

Exclusion Criteria:

• Growth hormone (GH) deficiency based on a GH stimulation test